Article Type
Changed
Sun, 05/01/2022 - 20:04

Key clinical point: Salty taste preference, always using table salt, and a greater high-salt and salt-preserved foods intake are associated with a higher risk for gastric cancer.

Major finding: The risk for gastric cancer was higher with salty vs. tasteless taste preference (adjusted odds ratio [aOR] 1.59; 95% CI 1.25-2.03), always vs. never using table salt (aOR 1.33; 95% CI 1.16-1.54), and the highest vs. lowest tertile of high-salt and salt-preserved foods intake (aOR 1.24; 95% CI 1.01-1.51). There was no significant association for the highest vs. lowest tertile of total sodium intake (aOR 1.08; 95% CI 0.82-1.43).

Study details: This study was an individual participant data meta-analysis of 25 studies including 10,283 patients with gastric cancer and 24,643 control individuals.

Disclosures: This study was supported by Portuguese Ministry of Science, Technology, and Higher Education; Instituto de Saúde Pública da Universidade do Porto; Associazione Italiana per la Ricerca sul Cancro; and others. The authors declared no conflicts of interest.

Source: Morais S et al. Salt intake and gastric cancer: A pooled analysis within the Stomach cancer Pooling (StoP) Project. Cancer Causes Control. 2022;33:779-791 (Mar 19). Doi: 10.1007/s10552-022-01565-y

Publications
Topics
Sections

Key clinical point: Salty taste preference, always using table salt, and a greater high-salt and salt-preserved foods intake are associated with a higher risk for gastric cancer.

Major finding: The risk for gastric cancer was higher with salty vs. tasteless taste preference (adjusted odds ratio [aOR] 1.59; 95% CI 1.25-2.03), always vs. never using table salt (aOR 1.33; 95% CI 1.16-1.54), and the highest vs. lowest tertile of high-salt and salt-preserved foods intake (aOR 1.24; 95% CI 1.01-1.51). There was no significant association for the highest vs. lowest tertile of total sodium intake (aOR 1.08; 95% CI 0.82-1.43).

Study details: This study was an individual participant data meta-analysis of 25 studies including 10,283 patients with gastric cancer and 24,643 control individuals.

Disclosures: This study was supported by Portuguese Ministry of Science, Technology, and Higher Education; Instituto de Saúde Pública da Universidade do Porto; Associazione Italiana per la Ricerca sul Cancro; and others. The authors declared no conflicts of interest.

Source: Morais S et al. Salt intake and gastric cancer: A pooled analysis within the Stomach cancer Pooling (StoP) Project. Cancer Causes Control. 2022;33:779-791 (Mar 19). Doi: 10.1007/s10552-022-01565-y

Key clinical point: Salty taste preference, always using table salt, and a greater high-salt and salt-preserved foods intake are associated with a higher risk for gastric cancer.

Major finding: The risk for gastric cancer was higher with salty vs. tasteless taste preference (adjusted odds ratio [aOR] 1.59; 95% CI 1.25-2.03), always vs. never using table salt (aOR 1.33; 95% CI 1.16-1.54), and the highest vs. lowest tertile of high-salt and salt-preserved foods intake (aOR 1.24; 95% CI 1.01-1.51). There was no significant association for the highest vs. lowest tertile of total sodium intake (aOR 1.08; 95% CI 0.82-1.43).

Study details: This study was an individual participant data meta-analysis of 25 studies including 10,283 patients with gastric cancer and 24,643 control individuals.

Disclosures: This study was supported by Portuguese Ministry of Science, Technology, and Higher Education; Instituto de Saúde Pública da Universidade do Porto; Associazione Italiana per la Ricerca sul Cancro; and others. The authors declared no conflicts of interest.

Source: Morais S et al. Salt intake and gastric cancer: A pooled analysis within the Stomach cancer Pooling (StoP) Project. Cancer Causes Control. 2022;33:779-791 (Mar 19). Doi: 10.1007/s10552-022-01565-y

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan: Gastric Cancer, May 2022
Gate On Date
Mon, 04/25/2022 - 20:45
Un-Gate On Date
Mon, 04/25/2022 - 20:45
Use ProPublica
CFC Schedule Remove Status
Mon, 04/25/2022 - 20:45
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article